Takeda Pharmaceuticals International AG
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 28 Apr 2026 | Jana Dabbelt Cabinet member | EUCOPE - Strasbourg | SRC |
| 28 Apr 2026 | Jana Dabbelt Cabinet member | EUCOPE - Strasbourg | — |
| 03 Dec 2025 | Ulla Schwager Head of Unit | Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector | SRC |
| 03 Dec 2025 | Ulla Schwager Head of Unit | Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector | — |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 25 Jun 2025 | Patricia Reilly Cabinet member | the EU biopharmaceutical landscape | SRC |
| 25 Jun 2025 | Patricia Reilly Cabinet member | the EU biopharmaceutical landscape | — |
| 20 Jan 2023 | Elina Melngaile Cabinet member | EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices | SRC |
| 20 Jan 2023 | Elina Melngaile Cabinet member | EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices | — |
| 14 Sept 2017 | Manuel Mateo-Goyet Cabinet member | eHealth | SRC |
| 14 Sept 2017 | Manuel Mateo-Goyet Cabinet member | eHealth | — |
Mission & Goals
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 244-year history in Japan. Established by our founding spirit and integral to every part of our business, Takeda-ism and our priorities (Patient, Trust, Reputation, Business) guide us in our efforts to achieve our Vision 2025. Takeda is headquartered in Tokyo, Japan and focuses its R&D on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. We aspire to bring our leadership in translating science into life-changing medicines to the next level, in our core focus areas: oncology, gastroentero (...)
EU Legislative Interests
We follow EU initiatives, policies and legislative files related to our Pharmaceuticals and Vaccines businesses. This includes topics such as R&D and clinical trials, data protection, relevant pharmaceutical legislation and initiatives, medical devices, trade & IP, environment.
Communication Activities
Mainly via participation at events organised by Trade Associations.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe. Takeda is member of EUCOPE (European Confederation of Pharmaceutical Enterpreneurs). Takeda is also member of PPTA Europe, Japanese Business Council Europe and MedTech Europe.
Organisation Members
For more details see www.takeda.com
Additional Information
Declaration as per guidelines from the EU Transparency Register. Source for EU funding as per Financial Transparency Register